Tonix Pharmaceuticals Holding Corp. Uncategorized Contracts & Agreements
30 Contracts & Agreements
- Description of Registrants Securities (Filed With SEC on April 1, 2024)
- Form of Securities Purchase Agreement (Filed With SEC on March 29, 2024)
- Form of Warrant Amendment Agreement (Filed With SEC on March 29, 2024)
- Form of Series E Warrant (Filed With SEC on March 29, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on March 29, 2024)
- Placement Agent Agreement, dated March 28, 2024, between Tonix Pharmaceuticals Holding Corp. and A.G.P./Alliance Global Partners (Filed With SEC on March 29, 2024)
- Placement Agent Agreement, dated December 20, 2023, between Tonix Pharmaceuticals Holding Corp. and A.G.P./Alliance Global Partners (Filed With SEC on December 21, 2023)
- Description of Registrants Securities (Filed With SEC on March 13, 2023)
- Form of Side Letter between Tonix Pharmaceuticals Holding Corp. and each investor, dated October 25, 2022 (Filed With SEC on October 25, 2022)
- Description of Registrants Securities (Filed With SEC on March 14, 2022)
- Description of Registrants Securities (Filed With SEC on March 15, 2021)
- Form of Investor Agreement, dated February 8, 2021, by and between the Company and the Purchasers thereunder (Filed With SEC on February 9, 2021)
- Description of Registrants Securities (Filed With SEC on March 24, 2020)
- TONIXPHARMACEUTICALS HOLDING CORP. $15,000,000 COMMONSTOCK SALESAGREEMENT (Filed With SEC on April 28, 2016)
- TONIX PHARMACEUTICALS HOLDING CORP. 509 Madison Avenue, Suite 306 New York, New York 10022 (Filed With SEC on March 19, 2014)
- TONIX PHARMACEUTICALS HOLDING CORP. 509 Madison Avenue, Suite 306 New York, New York 10022 (Filed With SEC on March 19, 2014)
- TONIX PHARMACEUTICALS HOLDING CORP. 509 Madison Avenue, Suite 306 New York, New York 10022 February 11, 2014 (Filed With SEC on February 14, 2014)
- TONIX PHARMACEUTICALS HOLDING CORP. 509 Madison Avenue, Suite 306 New York, New York 10022 October 15, 2013 (Filed With SEC on October 17, 2013)
- TONIX PHARMACEUTICALS HOLDING CORP. 509 Madison Avenue, Suite 306 New York, New York 10022 October 15, 2013 (Filed With SEC on October 17, 2013)
- TONIX PHARMACEUTICALS HOLDING CORP. 509 Madison Avenue, Suite 306 New York, New York 10022 October 15, 2013 (Filed With SEC on October 17, 2013)
- TONIX PHARMACEUTICALS HOLDING CORP. (Filed With SEC on December 27, 2012)
- Improved Oral Delivery of Cyclobenzaprine– Feasibility Proposal (Filed With SEC on April 3, 2012)
- FEASIBILITY AND OPTION AGREEMENT (Filed With SEC on April 3, 2012)
- FEASIBILITY AND OPTION AGREEMENT (Filed With SEC on February 3, 2012)
- SUBSCRIPTIONAGREEMENT (Filed With SEC on January 23, 2012)
- Exhibit 10.20 is filed herewith as a PDF reference. (Filed With SEC on December 27, 2011)
- Silicon ValleySan AntonioNew YorkTorontoLondonParisFrankfurtTokyoChennai (Filed With SEC on October 14, 2011)
- FEASIBILITY AND OPTION AGREEMENT (Filed With SEC on October 14, 2011)
- FINANCIAL PUBLIC RELATIONS LETTER OF AGREEMENT FOR TONIX Pharmaceuticals, Inc. (Filed With SEC on October 14, 2011)
- BACKGROUND (Filed With SEC on October 14, 2011)
